William D. Humphries - 22 Sep 2023 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Reporting relationship: Director
Issuer ticker: CLSD
Reported as of: 22 Sep 2023
Net transaction value: +$9,091
SEC form: 4
Accepted by SEC: 22 Sep 2023, 16:35:39 UTC
Prior SEC filing: 07 Jul 2023
Next SEC filing: 04 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Mark Ballantyne, Attorney-in-Fact

Key filing fact

William D. Humphries filed Form 4 for Clearside Biomedical, Inc. (CLSD) on 22 Sep 2023.

Key facts

This page summarizes William D. Humphries's Form 4 filing for Clearside Biomedical, Inc. (CLSD).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 22 Sep 2023, 16:35.

Change

Previous filing in this sequence was filed on 07 Jul 2023.
Current net transaction value: +$9,091.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLSD transaction

Common Stock

Options Exercise

Transaction value: $9,091
Shares: +22,727
Change %: +80%
Price: $0.4000
Shares after: 51,040
Date: 22 Sep 2023
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLSD transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -22,727
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 22 Sep 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 22,727
Exercise price: $0.4000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Fully vested and exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .